Published in Vaccine Weekly, July 3rd, 1995
Genital herpes simplex virus is the major cause of genital ulcerations in Europe and North America and seroprevalence studies have shown that between 10 percent and 20 percent of Europeans and North Americans between the ages of 20 and 45 have evidence of HSV-2 infection.
"Vaccines for preventing or treating genital herpes would be a major public health advance," researcher Andria Langenberg and colleagues wrote ("A Recombinant Glycoprotein...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly